Work

A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.744.744

Authors: Sarah Nikiforow, Haesook T Kim, Bhavjot Bindra, Sean McDonough, Brett Glotzbecker, Philippe Armand, John Koreth, Vincent T Ho, Edwin P Alyea, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin, Corey Cutler

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2581820269

FWCI:

Cites:

Cited by:

Related to: 10